Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
intravenous drugs
Manufacturing
Par Health recalls more IV bags for presence of cellulose
Par Health issued a voluntary recall of two lots of the IV barbiturate Brevital sodium that may be tainted with cellulose.
Joseph Keenan
Oct 12, 2026 9:04am
Otsuka venture yanks sodium chloride for IV over labeling issue
Sep 24, 2026 9:41am
Par Health recalls IV sedative, flagging contamination risk
Sep 22, 2026 2:10pm
B. Braun launches IV solution recall over particle concerns
Aug 20, 2026 10:44am
Otsuka forms joint venture to boost IV solution supply
Nov 14, 2024 8:40am
UPDATED: Baxter exits China IV fluids market amid US shortage
Oct 30, 2024 4:55pm